Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Trinity Biotech PLC (TRIB) had Debt to Capital Ratio of -0.61 for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$43.78M |
|
$-37.38M |
|
$26.90M |
|
$16.89M |
|
$59.57M |
|
$-15.79M |
|
$-21.39M |
|
$-37.18M |
|
$-37.18M |
|
$-37.38M |
|
$-37.38M |
|
$-37.38M |
|
$-37.38M |
|
$-15.79M |
|
$-13.11M |
|
18.58M |
|
18.58M |
|
$-2.00 |
|
$-2.00 |
|
| Balance Sheet Financials | |
$35.90M |
|
$5.30M |
|
$69.26M |
|
$105.17M |
|
$141.21M |
|
$27.17M |
|
$35.94M |
|
$177.15M |
|
$-71.98M |
|
$-128.97M |
|
$-71.98M |
|
19.34M |
|
| Cash Flow Statement Financials | |
$-5.93M |
|
$-6.22M |
|
$12.05M |
|
$5.17M |
|
$5.14M |
|
$-0.03M |
|
$0.32M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.25 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
-0.61 |
-1.92 |
|
38.57% |
|
-36.06% |
|
-36.06% |
|
-29.93% |
|
-84.91% |
|
-85.36% |
|
$-6.02M |
|
-- |
|
-- |
|
-- |
|
0.42 |
|
1.43 |
|
3.81 |
|
95.70 |
|
51.92% |
|
28.98% |
|
-35.54% |
|
83.41% |
|
$-3.72 |
|
$-0.32 |
|
$-0.32 |
|